MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.
The recall is now classified as Class II, meaning the consumption of affected products could cause "temporary or medically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback